Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence
Open Access
- 10 August 2020
- journal article
- review article
- Published by Elsevier BV in American Journal of Infection Control
- Vol. 49 (3), 375-384
- https://doi.org/10.1016/j.ajic.2020.08.003
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The Effect of Lactobacillus plantarum 299v on the Incidence of Clostridium difficile Infection in High Risk Patients Treated with AntibioticsNutrients, 2015
- Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a reviewClinical and Experimental Gastroenterology, 2015
- Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewAntibiotics, 2015
- Saccharomyces boulardii for the Prevention of Hospital Onset Clostridium difficile InfectionJournal of Gastrointestinal and Liver Diseases, 2015
- Pooling data on different probiotics is not appropriate to assess the efficacy of probioticsEuropean Journal of Pediatrics, 2014
- Effects of antibiotic therapy on the gastrointestinal microbiota and the influence ofLactobacillus caseiFood and Agricultural Immunology, 2013
- Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospitalCurrent Medical Research and Opinion, 2013
- Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrheaJournal of Medical Economics, 2011
- Lactobacillus and bifidobacteria combinations: A strategy to reduce hospital-acquired Clostridium difficile diarrhea incidence and mortalityMedical Hypotheses, 2009
- Impact of a Reduction in the Use of High-Risk Antibiotics on the Course of an Epidemic of Clostridium difficile-Associated Disease Caused by the Hypervirulent NAP1/027 StrainClinical Infectious Diseases, 2007